Cardiovascular risk assessment and baseline biomarkers

• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

• IOCN and BCOS ' Baseline Cardiac Biomarker Consensus Statement' - due for release November 2024

Myocarditis diagnosis, investigation and management:

• The Clatterbridge Cancer Centre Myocarditis Guideline 
• ESMO Management of toxicities from Immunotherapy 

• Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis

• Electrocardiographic features of immune checkpoint inhibitor associated myocarditis